PortfoliosLab logo

Annovis Bio, Inc. (ANVS)

Equity · Currency in USD · Last updated Sep 24, 2022

Company Info

ISINUS03615A1088
CUSIP03615A108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$15.54
Year Range$8.61 - $37.67
EMA (50)$13.70
EMA (200)$16.46
Average Volume$78.98K
Market Capitalization$129.56M

ANVSShare Price Chart


Chart placeholderClick Calculate to get results

ANVSPerformance

The chart shows the growth of $10,000 invested in Annovis Bio, Inc. in Jan 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $13,910 for a total return of roughly 39.10%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%AprilMayJuneJulyAugustSeptember
-2.41%
-19.28%
ANVS (Annovis Bio, Inc.)
Benchmark (^GSPC)

ANVSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M24.56%-10.55%
6M-8.32%-18.29%
YTD-24.12%-22.51%
1Y-59.18%-15.98%
5Y13.24%4.65%
10Y13.24%4.65%

ANVSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-13.71%-6.39%-5.99%-29.29%-2.75%23.53%1.41%0.87%15.00%
202132.36%156.21%9.11%-20.65%103.70%89.76%-59.77%9.61%-15.87%-16.47%-9.28%-26.93%
2020-32.01%-25.61%-38.14%28.33%15.32%-2.03%33.33%-18.10%1.26%-5.20%19.52%38.35%

ANVSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Annovis Bio, Inc. Sharpe ratio is -0.63. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.63
-0.78
ANVS (Annovis Bio, Inc.)
Benchmark (^GSPC)

ANVSDividend History


Annovis Bio, Inc. doesn't pay dividends

ANVSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-88.97%
-23.00%
ANVS (Annovis Bio, Inc.)
Benchmark (^GSPC)

ANVSWorst Drawdowns

The table below shows the maximum drawdowns of the Annovis Bio, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Annovis Bio, Inc. is 92.88%, recorded on May 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.88%Jul 14, 2021219May 24, 2022
-73.93%Jan 30, 202045Apr 2, 2020197Jan 13, 2021242
-43.94%Mar 18, 202133May 4, 202113May 21, 202146
-25.67%May 24, 20214May 27, 20214Jun 3, 20218
-25.05%Feb 23, 20219Mar 5, 20216Mar 15, 202115
-17.86%Jun 22, 20212Jun 23, 20217Jul 2, 20219
-13.29%Feb 5, 20211Feb 5, 20212Feb 9, 20213
-6.06%Jun 9, 20211Jun 9, 20211Jun 10, 20212
-5.95%Jan 27, 20211Jan 27, 20214Feb 2, 20215
-5.61%Jun 17, 20211Jun 17, 20212Jun 21, 20213

ANVSVolatility Chart

Current Annovis Bio, Inc. volatility is 112.59%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%AprilMayJuneJulyAugustSeptember
112.59%
23.28%
ANVS (Annovis Bio, Inc.)
Benchmark (^GSPC)